SCHEMBL7512289

SCHEMBL7512289

O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd].[Pd].[Pd]

nearest known ligand 0.95

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.95
CYP2C9 P11712 3/20 0.95
F3 P13726 3/20 0.95
CYP1A2 P05177 3/20 0.95
PLIN1 O60240 2/20 0.95
LMNA P02545 2/20 0.95
RECQL P46063 2/20 0.95
PLIN5 Q00G26 2/20 0.95
ABHD5 Q8WTS1 2/20 0.95
CYP2D6 P10635 2/20 0.95
ALDH1A1 P00352 2/20 0.95
SMN1; SMN2 Q16637 1/20 0.95
HDAC3 O15379 2/20 0.70
HDAC4 P56524 2/20 0.70
HDAC1 Q13547 2/20 0.70
HDAC2 Q92769 2/20 0.70
HDAC8 Q9BY41 2/20 0.70
HDAC6 Q9UBN7 2/20 0.70
TNKS O95271 1/20 0.70
HCAR2 Q8TDS4 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL546073 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL509571 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL1646390 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL5111 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL14832106 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL2438441 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL18039478 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL187662 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL21879664 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL2639578 1.00 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462073-B2 METALLOPROTEASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION 2002-10-08 US disclosed
US-20020006922-A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors AMERICAN CYANAMID COMPANY (US) 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006922-A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors MMP12, ADAM33, MMP2 MAPT 4852/4885CYP2C9 2804/4885F3 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.